Foley & Lardner LLP
Combinations for the treatment of cancer
Described herein are combinations comprising a therapeutically effective amount of a first agent and a therapeutically effective amount of a second agent, wherein the first agent is an inhibitor of ALK, ROS1, TrkA, TrkB, or TrkC activity, or a combination thereof, and methods of using such combinations in the treatment of patients having cancer.
IGNYTA, INC.
A A A A C A A A A C A C C A A A
A61K A61K A61K A61P C12Q A61K A61K A61K A61K C12Q A61K C12Q C12Q A61K A61K A61K
inventional inventional inventional inventional additional inventional inventional inventional inventional inventional inventional inventional additional inventional inventional inventional
Jonathan Ee-ren Zachary D. Ge Gang
Lim Hornby Wei Li